These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20647403)

  • 1. An evidence-based microsimulation model for colorectal cancer: validation and application.
    Rutter CM; Savarino JE
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1992-2002. PubMed ID: 20647403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of screening and follow-up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC-AIM microsimulation model.
    Fisher DA; Saoud L; Hassmiller Lich K; Fendrick AM; Ozbay AB; Borah BJ; Matney M; Parton M; Limburg PJ
    Cancer Med; 2021 Apr; 10(8):2855-2864. PubMed ID: 33314646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calibration and Validation of the Colorectal Cancer and Adenoma Incidence and Mortality (CRC-AIM) Microsimulation Model Using Deep Neural Networks.
    Vahdat V; Alagoz O; Chen JV; Saoud L; Borah BJ; Limburg PJ
    Med Decis Making; 2023 Aug; 43(6):719-736. PubMed ID: 37434445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
    United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMOST: an open-source framework for the microsimulation of colorectal cancer screening strategies.
    Prakash MK; Lang B; Heinrich H; Valli PV; Bauerfeind P; Sonnenberg A; Beerenwinkel N; Misselwitz B
    BMC Med Inform Decis Mak; 2017 Jun; 17(1):80. PubMed ID: 28583127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions.
    Wong MC; Ching JY; Chiu HM; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Ng SC; Wu JC; Chan FK; Sung JJ
    Am J Gastroenterol; 2016 Nov; 111(11):1621-1629. PubMed ID: 26977757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy.
    Tjaden JM; Hause JA; Berger D; Duveneck SK; Jakate SM; Orkin BA; Hubbard EL; Melson JE
    Surg Endosc; 2018 Jul; 32(7):3108-3113. PubMed ID: 29340817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
    Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
    Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.
    Alatise OI; Ayandipo OO; Adeyeye A; Seier K; Komolafe AO; Bojuwoye MO; Afuwape OO; Zauber A; Omisore A; Olatoke S; Akere A; Famurewa O; Gonen M; Irabor DO; Kingham TP
    Cancer; 2018 Jul; 124(13):2766-2773. PubMed ID: 29645077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When History and Heterogeneity Matter: A Tutorial on the Impact of Markov Model Specifications in the Context of Colorectal Cancer Screening.
    Townsley RM; Koutouan PR; Mayorga ME; Mills SD; Davis MM; Hasmiller Lich K
    Med Decis Making; 2022 Oct; 42(7):845-860. PubMed ID: 35543440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of screening for colorectal cancer: Development, documentation and validation of a multistate Markov model.
    Heisser T; Hoffmeister M; Brenner H
    Int J Cancer; 2021 Apr; 148(8):1973-1981. PubMed ID: 33320964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal timing of a colonoscopy screening schedule depends on adenoma detection, adenoma risk, adherence to screening and the screening objective: A microsimulation study.
    Zaika V; Prakash MK; Cheng CY; Schlander M; Lang BM; Beerenwinkel N; Sonnenberg A; Krupka N; Misselwitz B; Poleszczuk J
    PLoS One; 2024; 19(5):e0304374. PubMed ID: 38787836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A progressive three-state model to estimate time to cancer: a likelihood-based approach.
    Akwiwu EU; Klausch T; Jodal HC; Carvalho B; Løberg M; Kalager M; Berkhof J; Coupé VMH
    BMC Med Res Methodol; 2022 Jun; 22(1):179. PubMed ID: 35761181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of screening strategies for colorectal cancer.
    Barzi A; Lenz HJ; Quinn DI; Sadeghi S
    Cancer; 2017 May; 123(9):1516-1527. PubMed ID: 28117881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer.
    Park CH; Kim NH; Park JH; Park DI; Sohn CI; Jung YS
    Gastrointest Endosc; 2018 Jul; 88(1):128-135. PubMed ID: 29510145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials.
    Lew JB; Greuter MJE; Caruana M; He E; Worthington J; St John DJ; Macrae FA; Feletto E; Coupé VMH; Canfell K
    Med Decis Making; 2020 Aug; 40(6):815-829. PubMed ID: 32845232
    [No Abstract]   [Full Text] [Related]  

  • 18. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
    Cancer Epidemiol; 2013 Jun; 37(3):278-83. PubMed ID: 23491770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment tool.
    Ladabaum U; Patel A; Mannalithara A; Sundaram V; Mitani A; Desai M
    Cancer; 2016 Sep; 122(17):2663-70. PubMed ID: 27219715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
    Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
    Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.